Propranolol and metoprolol enhance the anticonvulsant action of valproate and diazepam against maximal electroshock

The anticonvulsive potential of classical antiepileptics co-administered with β-adrenergic receptor antagonists against generalized tonic–clonic seizures was evaluated in the model of maximal electroshock (MES)-induced convulsions. Propranolol, acebutolol, metoprolol and atenolol were tested in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacology, biochemistry and behavior biochemistry and behavior, 2002-01, Vol.71 (1), p.223-231
Hauptverfasser: Luchowska, Elżbieta, Luchowski, Piotr, Wielosz, Marian, Kleinrok, Zdzisław, Czuczwar, Stanisław J., Urbańska, Ewa M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The anticonvulsive potential of classical antiepileptics co-administered with β-adrenergic receptor antagonists against generalized tonic–clonic seizures was evaluated in the model of maximal electroshock (MES)-induced convulsions. Propranolol, acebutolol, metoprolol and atenolol were tested in the doses not affecting the electroconvulsive threshold. Propranolol and metoprolol lowered the ED 50 of valproate and diazepam. Acebutolol reduced valproate's but not diazepam's ED 50 value. In contrast, hydrophilic atenolol, not penetrating via blood–brain barrier, affected neither the action of valproate nor diazepam. None of the studied drugs changed the protective activity of carbamazepine and phenytoin against MES. β-blockers per se did not alter the motor performance of mice. Moreover, propranolol and metoprolol did not influence diazepam-evoked impairment of locomotor activity. The free plasma and brain levels of antiepileptic drugs were not affected by β-blockers. In conclusion, the use of certain β-adrenoceptor antagonists, such as propranolol and metoprolol, might improve the antiepileptic potential of valproate and diazepam.
ISSN:0091-3057
1873-5177
DOI:10.1016/S0091-3057(01)00654-2